Your browser doesn't support javascript.
loading
Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy.
Seferovic, Petar M; Tsutsui, Hiroyuki; Mcnamara, Dennis M; Ristic, Arsen D; Basso, Cristina; Bozkurt, Biykem; Cooper, Leslie T; Filippatos, Gerasimos; Ide, Tomomi; Inomata, Takayuki; Klingel, Karin; Linhart, Ales; Lyon, Alexander R; Mehra, Mandeep R; Polovina, Marija; Milinkovic, Ivan; Nakamura, Kazufumi; Anker, Stefan D; Veljic, Ivana; Ohtani, Tomohito; Okumura, Takahiro; Thum, Thomas; Tschöpe, Carsten; Rosano, Giuseppe; Coats, Andrew J S; Starling, Randall C.
Afiliación
  • Seferovic PM; Serbian Academy of Sciences and Arts, Belgrade, Serbia. Electronic address: seferovic.petar@gmail.com.
  • Tsutsui H; Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Mcnamara DM; Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Ristic AD; Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Basso C; Cardiovascular Pathology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
  • Bozkurt B; Winters Center for Heart Failure, Cardiovascular Research Institute, Baylor College of Medicine, Michael E. DeBakey VA Medical Center, Houston, Texas.
  • Cooper LT; Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida.
  • Filippatos G; Attikon University Hospital, Department of Cardiology, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Ide T; Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Inomata T; Department of Cardiovascular Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
  • Klingel K; Cardiopathology, Institute for Pathology, University Hospital, Tuebingen, Germany.
  • Linhart A; Department of Cardiovascular Medicine, Charles University, Prague, Czech Republic.
  • Lyon AR; National Heart and Lung Institute, Imperial College and Royal Brompton Hospital, London, UK.
  • Mehra MR; Heart and Vascular Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Polovina M; Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Milinkovic I; Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Nakamura K; Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Anker SD; Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin Berlin, Germany.
  • Veljic I; Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
  • Ohtani T; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Okumura T; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Thum T; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany; Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
  • Tschöpe C; Berlin Institute of Health (BIH) and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Department of Cardiology, Campus Virchow Klinikum, Charite University, Berlin, Germany.
  • Rosano G; Department of Medical Sciences, IRCCS San Raffaele, Rome, Italy, and Cardiology Clinical Academic Group, St George's Hospitals NHS Trust.
  • Coats AJS; Monash University, Australia, and University of Warwick, Coventry, UK.
  • Starling RC; Cleveland Clinic, Cleveland Ohio.
J Card Fail ; 27(7): 727-743, 2021 07.
Article en En | MEDLINE | ID: mdl-34022400
ABSTRACT
Endomyocardial biopsy (EMB) is an invasive procedure, globally most often used for the monitoring of heart transplant rejection. In addition, EMB can have an important complementary role to the clinical assessment in establishing the diagnosis of diverse cardiac disorders, including myocarditis, cardiomyopathies, drug-related cardiotoxicity, amyloidosis, other infiltrative and storage disorders, and cardiac tumors. Improvements in EMB equipment and the development of new techniques for the analysis of EMB samples has significantly improved the diagnostic precision of EMB. The present document is the result of the Trilateral Cooperation Project between the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America, and the Japanese Heart Failure Society. It represents an expert consensus aiming to provide a comprehensive, up-to-date perspective on EMB, with a focus on the following main issues (1) an overview of the practical approach to EMB, (2) an update on indications for EMB, (3) a revised plan for heart transplant rejection surveillance, (4) the impact of multimodality imaging on EMB, and (5) the current clinical practice in the worldwide use of EMB.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Corazón / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Card Fail Asunto de la revista: CARDIOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Corazón / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Card Fail Asunto de la revista: CARDIOLOGIA Año: 2021 Tipo del documento: Article